NLS Pharmaceutics Ltd (NLSP)
0.138
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.1458
+0.01
(+5.65%)
After-Hours: 20:00
NLS Pharmaceutics Cash from Operations (TTM): -13.51M for June 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
AC Immune SA | -67.27M |
CRISPR Therapeutics AG | -260.38M |
Addex Therapeutics Ltd | -8.901M |
Molecular Partners AG | -65.71M |
MoonLake Immunotherapeutics | -42.78M |